Aigen Investment Management, LP Agios Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$24.81 - $31.52 $243,485 - $309,337	9,814 New	9,814 $275,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $767,549 - $1.08 Million	-23,112 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$33.87 - $55.93 $782,803 - $1.29 Million	23,112 New	23,112 $809,000
Q2 2020 Aug 10, 2020	SELL	$34.45 - $53.48 $761,827 - $1.18 Million	-22,114 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$31.52 - $53.81 $429,806 - $733,753	13,636 Added 160.84%	22,114 $785,000
Q4 2019 Feb 04, 2020	BUY	$30.08 - $50.59 $255,018 - $428,902	8,478 New	8,478 $405,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.